# Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users

> **NCT05053126** · PHASE4 · COMPLETED · sponsor: **Viatris Specialty LLC** · enrollment: 60 (actual)

## Conditions studied

- Abuse Potential

## Interventions

- **DRUG:** Pregabalin 300mg
- **DRUG:** pregabalin 450 mg
- **DRUG:** Pregabalin 300 mg with oxycodone 20 mg
- **DRUG:** pregabalin 450 mg with oxycodone 20 mg
- **DRUG:** oxycodone 20 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05053126
- **Lead sponsor:** Viatris Specialty LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-27
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05053126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05053126, "Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05053126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*